Cargando…

Evaluation of prothrombotic risk of two PROC hotspot mutations (Arg189Trp and Lys193del) in Chinese population: a retrospective study

BACKGROUND: R189W and K193del of protein C (PC) were hotspot mutations in Chinese population with venous thromboembolism (VTE), but almost two-thirds of patients with above mutations coexisting with other genetically or aquiredly prothrombotic risk factors. The aim of this study is to clarify the in...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lei, Li, Jian, Wu, Xi, Wu, Wenman, Ding, Qiulan, Qian, Baohua, Wang, Xuefeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546776/
https://www.ncbi.nlm.nih.gov/pubmed/37789321
http://dx.doi.org/10.1186/s12959-023-00548-6
_version_ 1785114931975159808
author Li, Lei
Li, Jian
Wu, Xi
Wu, Wenman
Ding, Qiulan
Qian, Baohua
Wang, Xuefeng
author_facet Li, Lei
Li, Jian
Wu, Xi
Wu, Wenman
Ding, Qiulan
Qian, Baohua
Wang, Xuefeng
author_sort Li, Lei
collection PubMed
description BACKGROUND: R189W and K193del of protein C (PC) were hotspot mutations in Chinese population with venous thromboembolism (VTE), but almost two-thirds of patients with above mutations coexisting with other genetically or aquiredly prothrombotic risk factors. The aim of this study is to clarify the independent contributions of R189W or K193del to VTE risk. METHODS: 490 unrelated patients with a personal history of VTE and 410 healthy participants were enrolled in this study. Data of their demographics, family history, genetic and acquired thrombosis risk factors were collected and statistically analyzed. RESULTS: PC R189W and K193del were identified in 3/410 (0.7%) and 7/410 (1.7%) healthy controls, and in 27/490 (5.5%) and 43/490 (8.8%) patients with VTE, respectively. Notably, about 70% of these mutant carriers combined with other genetic or acquired thrombophilic factors. After adjustment for age, gender, other inherited and acquired risk factors, we demonstrated that R189W and K193del were associated with 5.781-fold and 4.365-fold increased risk of VTE, respectively, which were significantly lower than the prothrombotic risk of anticoagulant deficiencies induced from rare mutations. Independent R189W or K193del mutation was not associated with earlier first-onset age as well as higher recurrent rate of VTE. However, combination of other genetic or acquired thrombophilic factors had supra-additive effects on those consequences. The more additional risk factors the patients had, the younger first-onset ages and higher risk of recurrence would be. CONCLUSIONS: As the most frequent mutations for PC deficiency in Chinese population, both R189W and K193del mutations had limited independent contributions to VTE development compared with other rare mutations in PROC gene, but may act in concert with other genetic defects or acquired thrombotic risk factors to produce the final severe phenotype. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12959-023-00548-6.
format Online
Article
Text
id pubmed-10546776
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105467762023-10-04 Evaluation of prothrombotic risk of two PROC hotspot mutations (Arg189Trp and Lys193del) in Chinese population: a retrospective study Li, Lei Li, Jian Wu, Xi Wu, Wenman Ding, Qiulan Qian, Baohua Wang, Xuefeng Thromb J Research BACKGROUND: R189W and K193del of protein C (PC) were hotspot mutations in Chinese population with venous thromboembolism (VTE), but almost two-thirds of patients with above mutations coexisting with other genetically or aquiredly prothrombotic risk factors. The aim of this study is to clarify the independent contributions of R189W or K193del to VTE risk. METHODS: 490 unrelated patients with a personal history of VTE and 410 healthy participants were enrolled in this study. Data of their demographics, family history, genetic and acquired thrombosis risk factors were collected and statistically analyzed. RESULTS: PC R189W and K193del were identified in 3/410 (0.7%) and 7/410 (1.7%) healthy controls, and in 27/490 (5.5%) and 43/490 (8.8%) patients with VTE, respectively. Notably, about 70% of these mutant carriers combined with other genetic or acquired thrombophilic factors. After adjustment for age, gender, other inherited and acquired risk factors, we demonstrated that R189W and K193del were associated with 5.781-fold and 4.365-fold increased risk of VTE, respectively, which were significantly lower than the prothrombotic risk of anticoagulant deficiencies induced from rare mutations. Independent R189W or K193del mutation was not associated with earlier first-onset age as well as higher recurrent rate of VTE. However, combination of other genetic or acquired thrombophilic factors had supra-additive effects on those consequences. The more additional risk factors the patients had, the younger first-onset ages and higher risk of recurrence would be. CONCLUSIONS: As the most frequent mutations for PC deficiency in Chinese population, both R189W and K193del mutations had limited independent contributions to VTE development compared with other rare mutations in PROC gene, but may act in concert with other genetic defects or acquired thrombotic risk factors to produce the final severe phenotype. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12959-023-00548-6. BioMed Central 2023-10-03 /pmc/articles/PMC10546776/ /pubmed/37789321 http://dx.doi.org/10.1186/s12959-023-00548-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Li, Lei
Li, Jian
Wu, Xi
Wu, Wenman
Ding, Qiulan
Qian, Baohua
Wang, Xuefeng
Evaluation of prothrombotic risk of two PROC hotspot mutations (Arg189Trp and Lys193del) in Chinese population: a retrospective study
title Evaluation of prothrombotic risk of two PROC hotspot mutations (Arg189Trp and Lys193del) in Chinese population: a retrospective study
title_full Evaluation of prothrombotic risk of two PROC hotspot mutations (Arg189Trp and Lys193del) in Chinese population: a retrospective study
title_fullStr Evaluation of prothrombotic risk of two PROC hotspot mutations (Arg189Trp and Lys193del) in Chinese population: a retrospective study
title_full_unstemmed Evaluation of prothrombotic risk of two PROC hotspot mutations (Arg189Trp and Lys193del) in Chinese population: a retrospective study
title_short Evaluation of prothrombotic risk of two PROC hotspot mutations (Arg189Trp and Lys193del) in Chinese population: a retrospective study
title_sort evaluation of prothrombotic risk of two proc hotspot mutations (arg189trp and lys193del) in chinese population: a retrospective study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546776/
https://www.ncbi.nlm.nih.gov/pubmed/37789321
http://dx.doi.org/10.1186/s12959-023-00548-6
work_keys_str_mv AT lilei evaluationofprothromboticriskoftwoprochotspotmutationsarg189trpandlys193delinchinesepopulationaretrospectivestudy
AT lijian evaluationofprothromboticriskoftwoprochotspotmutationsarg189trpandlys193delinchinesepopulationaretrospectivestudy
AT wuxi evaluationofprothromboticriskoftwoprochotspotmutationsarg189trpandlys193delinchinesepopulationaretrospectivestudy
AT wuwenman evaluationofprothromboticriskoftwoprochotspotmutationsarg189trpandlys193delinchinesepopulationaretrospectivestudy
AT dingqiulan evaluationofprothromboticriskoftwoprochotspotmutationsarg189trpandlys193delinchinesepopulationaretrospectivestudy
AT qianbaohua evaluationofprothromboticriskoftwoprochotspotmutationsarg189trpandlys193delinchinesepopulationaretrospectivestudy
AT wangxuefeng evaluationofprothromboticriskoftwoprochotspotmutationsarg189trpandlys193delinchinesepopulationaretrospectivestudy